These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24738288)

  • 21. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
    Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of vaccine-preventable diseases.
    Hinman A
    Annu Rev Public Health; 1999; 20():211-29. PubMed ID: 10352857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 – conclusions and recommendations.
    Wkly Epidemiol Rec; 2016 Dec; 91(48):561-82. PubMed ID: 27922031
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccination recommendations for Germany.
    Wiese-Posselt M; Tertilt C; Zepp F
    Dtsch Arztebl Int; 2011 Nov; 108(45):771-9; quiz 780. PubMed ID: 22163258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanded programme on immunization.
    Keja K; Chan C; Hayden G; Henderson RH
    World Health Stat Q; 1988; 41(2):59-63. PubMed ID: 3176515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Means to improvement of epidemiologic control of indication of causative agents of infectious diseases].
    Onishchenko GG; Ezhlova EB; Demina IuV; Mel'nikova AL; Smolenskiĭ VIu
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):20-30. PubMed ID: 24605671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sanitary and epidemiological well-being: topical problems].
    Onishchenko GG
    Gig Sanit; 2006; (5):4-10. PubMed ID: 17087198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood vaccinations and risk of acute lymphoblastic leukaemia in children.
    Søegaard SH; Rostgaard K; Schmiegelow K; Kamper-Jørgensen M; Hargreave M; Hjalgrim H; Hviid A
    Int J Epidemiol; 2017 Jun; 46(3):905-913. PubMed ID: 28431124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving child survival through immunisation.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Actual problems of creation of informational-analytical system for rapid control of epidemics of infectious diseases].
    Boev BV; Semenenko TA; Bondarenko VM; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):37-42. PubMed ID: 22308725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Topical problems in the provision of the Russian Federation's population with sanitary-and-epidemiological well-being].
    Onishchenko GG
    Gig Sanit; 2008; (2):4-15. PubMed ID: 18507165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV; Iuminova NV
    Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The control of viral diseases in the developing countries with the use of existing vaccines].
    Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):77-82. PubMed ID: 1759532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines and biologicals. Part I.
    Strategic Advisory Group of Experts.
    Wkly Epidemiol Rec; 2001 Nov; 76(48):373-80. PubMed ID: 11764557
    [No Abstract]   [Full Text] [Related]  

  • 36. A perspective on controlling vaccine-preventable diseases among children in Liberia.
    Weeks RM
    Infect Control; 1984 Nov; 5(11):538-41. PubMed ID: 6568218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.
    Arístegui J; Usonis V; Coovadia H; Riedemann S; Win KM; Gatchalian S; Bock HL
    Int J Infect Dis; 2003 Jun; 7(2):143-51. PubMed ID: 12839717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Topical problems of the modern epidemiology (data for presentation at the all-Russian scientific conference "The problems of modern epidemiology. Perspective means and methods for the laboratory diagnosis and prevention of urgent infections")].
    Onishchenko G G
    Gig Sanit; 2011; (4):4-13. PubMed ID: 21901882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of vaccine-preventable diseases.
    Solomon IH; Milner DA
    Histopathology; 2017 Jan; 70(1):109-122. PubMed ID: 27960239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.